The OPME (Orthotics, Prosthetics, and Special Materials) sector continues to grow steadily in Brazil, driven by technological advances, an aging population, and increased demand for increasingly complex and specialized surgical procedures.
According to data from the Brazilian Medical Devices Industry Association (ABIIS), consumption of medical devices grew 5.2% in 2024 and showed even more significant growth of 7.3% in the first half of 2025 alone. Projections also reinforce this positive scenario: the prosthetics and orthotics segment is expected to grow from US$ 156 million to US$ 208.8 million by 2030.
This growth, however, has been accompanied by significant structural changes in the sector.
More demand, more requirements
As the market expands, there is a downward trend in average OPME prices. This movement puts pressure on the entire chain and requires suppliers to achieve ever-higher levels of operational efficiency, strict compliance, and absolute reliability in their processes.
In this context, it is not enough to simply meet growing demand. It is essential to ensure quality, traceability, and safety at every stage—from supply to end use in the operating room.
The strategic role of Implamed
It is in this challenging and dynamic scenario that Implamed reinforces its strategic positioning in the sector. The company's operations are guided by pillars that are becoming increasingly essential in light of market developments:
• Certified quality, in line with technical and regulatory standards;
• Complete traceability, with audited and transparent processes;
• Efficient logistics, ensuring agility, predictability, and security;
• Ethical and transparent relationships with hospitals, doctors, and partners.
These advantages allow Implamed to act not only as a supplier, but also as a strategic partner for healthcare institutions seeking excellence in care and safety in procedures.
Trust that impacts results
In a constantly changing industry, one premise remains unchanged: safe surgeries begin with reliable materials. The choice of OPME supplier directly impacts clinical outcomes, hospital efficiency, and the confidence of doctors and patients.
It is with this commitment that Implamed continues to operate on a daily basis—monitoring developments in the sector, anticipating demands, and delivering solutions that combine quality, safety, and responsibility.
